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INTRODUCTION:  Primary  endocrine  cell  tumors  in  the  gallbladder  are  uncommon,  and  the  coexistence  of
an  endocrine  cell  tumor  and  adenocarcinoma,  squamous  cell  carcinoma,  and  sarcomatoid  components
is  extremely  rare.
PRESENTATION  OF  CASE:  A  rare  case  of adeno-endocrine  cell  carcinoma  of  the  gallbladder  in an  81-year-old
woman  is reported.  Abdominal  ultrasonography  (US)  revealed  a hypo-echoic,  solid  tumor,  2.0  cm  ×  1.8 cm
in  size,  at  the  fundus  of the  gallbladder.  On  computed  tomography  (CT),  the  tumor  was  well-enhanced,
well-demarcated,  and  homogeneous.  The  tumor,  which  was  papillary,  protruded  into  the  gallbladder  with
no  direct  invasion  to the  liver.  The  tumor  was diagnosed  as  gallbladder  carcinoma;  its  depth  appeared
not  to pass the  subserosa  layer.  A cholecystectomy  and  hepatic  bed  resection  with  regional  lymph  node
dissection  were  performed.  Histologically,  the tumor  consisted  of several  components,  including  well
to  poorly  differentiated  papillary  and  tubular  adenocarcinoma  with  squamous  and  sarcomatoid  differ-
entiations,  and  endocrine  cell carcinoma.  Histochemical  studies  of  these  tumor  cells  were  positive  for
chromogranin  A, synaptophysin,  and  cluster  of  differentiation  56 (CD56).  The  lymph  node  consisted  of
metastatic  adeno-endocrine  carcinoma.  The  patient  survived  and  has remained  disease-free  for  4  years
without  adjuvant  chemotherapy.
DISCUSSION: Adeno-endocrine  cell  carcinoma  of the gallbladder  generally  has  a poor prognosis.
CONCLUSION: The  present  case  suggests  that adeno-endocrine  cell  carcinoma  with  various  components
may  be  derived  from  a common  precursor  cell.  This  observation  would  require  further  investigation.
gical  © 2013 Sur
. Introduction
Endocrine cell carcinoma is most commonly found in the gas-
rointestinal tract, especially in the appendix, and the lung. Tahara
t al. proposed the term “endocrine cell carcinoma” in 1988, and
t was classiﬁed into classical carcinoid and endocrine cell car-
inoma with more malignant potential.1 Primary endocrine cell
umors in the gallbladder are uncommon, and the coexistence of
n endocrine cell tumor and adenocarcinoma, squamous cell carci-
oma, and sarcomatoid components is extremely rare. The present
ase may  represent the ﬁrst reported case of a varied “composite”
umor in the gallbladder. A review of the literature is also provided.
. Presentation of caseAn 81-year old woman was admitted to our hospital in August
005 after she completed a routine annual medical examination.
he had been treated for diabetes mellitus and hypertension. No
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clinical signs of tumor hormonal activity were observed. Physi-
cal examination was  also unremarkable. Abdominal US showed a
protruding, hypo-echoic mass with an irregular surface at the fun-
dus of the gallbladder, and some gallbladder stones were detected
(Fig. 1). The results of laboratory tests on admission revealed that
aminotransferase, alanine aminotransferase, -guanosine triphos-
phate, and alkaline phosphatase levels were within the normal
ranges. The levels of tumor markers, such as carbohydrate antigen
19-9 and carcinoembryonic antigen, were also within the nor-
mal ranges. On CT, the tumor was irregular, homogeneous, and
strongly enhanced, and it appeared to extend no deeper than the
subserosa layer. The lymph node behind the head of the pancreas
was swollen (Fig. 2). T2-weighted magnetic resonance imaging
(MRI) showed a papillary high-intensity tumor that did not directly
invade the liver (Fig. 3). On laparotomy, neither ascites nor perit-
oneal dissemination was observed. A cholecystectomy and hepatic
bed resection, including regional lymph node dissection, were per-
formed. The operation time was 3 h and 12 min. Blood loss was
Open access under CC BY-NC-ND license.150 ml  Macroscopically, the tumor was 20 × 40 mm in size, and it
appeared to be an elastic, hard, white mass at the fundus of the
gallbladder (Fig. 4). All specimens were processed in the routine
manner for parafﬁn embedding, and 5-m-thick sections were
Y-NC-ND license. 
CASE  REPORT  –  OPEN  ACCESS
T. Abe et al. / International Journal of Surgery Case Reports 4 (2013) 504– 507 505
Fig. 1. Abdominal ultrasonography reveals a hypo-echoic, solid tumor, 2.0 × 1.8 cm,
at the fundus of the gallbladder.
Fig. 2. CT reveals that the tumor is irregular (white arrowheads), homogeneous,
and  enhanced, and the lymph node behind the head of the pancreas head is swollen
(white  arrow).
Fig. 3. T2-weighted MRI  shows a papillary high-intensity tumor that does directly
invade  the liver (white arrowheads).Fig. 4. Macroscopic observation shows that the specimen is an elastic, hard, white
tumor at the fundus of the gallbladder (white arrow).
cut and stained with hematoxylin and eosin. Histologically, the
tumor proliferation reached to the subserosa layer, but the liver
parenchyma was  intact. There was no vascular or lymphatic per-
meation. The tumor consisted of several components, well to poorly
differentiated papillary and tubular adenocarcinoma with squa-
mous and sarcomatoid components and endocrine cell carcinoma.
Histochemical studies of these tumor cells were positive for chro-
mogranin A, synaptophysin, and CD56 (Figs. 5a–c, 6a–c). In the
enlarged lymph node, metastatic carcinoma cells were detected,
although perineural tumor invasion was not noted.
Thus, a nonfunctioning and well to poorly differentiated
endocrine adenocarcinoma with various differentiations was  diag-
nosed based on the above pathologic ﬁndings. The patient was
discharged on the 13th day after the operation without any com-
plications. This patient underwent a curative surgical resection and
remains disease-free 4 years later.
3. Discussion
To the best of our knowledge, this is very rare report of a compos-
ite tumor of adeno-endocrine cell and squamous cell carcinoma and
sarcoma arising from the gallbladder. The typical classiﬁcation of
carcinoid tumors is based on their embryonic gut origin, but the lit-
erature shows widespread and inconsistent dualistic classiﬁcations
of “typical” versus “atypical” carcinoid with the usual reference to
their degree of differentiation. “Typical” carcinoids, by deﬁnition,
are tumors with neuroendocrine differentiation and the classical
histological architecture of trabecular, insular, or ribbon-like cell
clusters, with no or minimal cellular pleomorphism and sparse
mitoses.2 “Atypical” carcinoids refer to aggressive forms of poorly
differentiated carcinoid tumors with increased mitotic activity and
absent or limited necrosis with a poor prognosis.2,3
Joel ﬁrst described a case of carcinoid tumor of the gallbladder in
1929.4 Since then, almost 50 cases, including the present case, have
been reported, accounting for 0.2% of all carcinoid tumors.5–10 The
typical clinical symptoms are jaundice and right upper quadrant
pain. In most cases, the diagnosis was incidental after histological
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Fig. 5. (a–c): Histologically, the gallbladder tumor consists of three components:
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Fig. 6. (a–c): (a) The tumor cells are positive for synaptophysin (synaptophysin,
a)  well to poorly differentiated papillary adenocarcinoma; (b) squamous differen-
iation;  and (c) sarcomatoid differentiation.
xamination of gallbladder specimens. The difﬁculty of making the
urrent diagnosis was due to the similarity of the radiological ﬁnd-
ngs to those of carcinoma of the gallbladder.
The origin of adeno-endocrine cell carcinoma of the gallbladder
s still unclear. Some studies suggest that genetically unstable pro-
enitor cells or undifferentiated, omnipotent stem cells can play
ot only an important role in embryonic development, but also
n oncogenesis. This supports the hypothesis that the histogene-
is of carcinoid tumors is that they originate from multipotential
tem cells that have the ability to differentiate towards neuroen-
ocrine and glandular cell types.6 In the current case, the apparent
ransitional zone was not detected, but the presence of various
omponents, such as adeno-endocrine cell and squamous and sar-
omatoid differentiations, in the same tumor suggests that they
ay arise from a common precursor cell.7,11 Only four cases of com-
osite tumor of adeno-endocrine cell carcinoma and squamous cell
arcinoma of the gallbladder have been reported (Table 1).12–15 The
resent case is the ﬁrst to show multidirectional differentiation,
ith squamous and sarcomatoid components.×200).  (b) In addition, the tumor cells show positivity for chromogranin (chromo-
granin,  ×200). (c) The tumor cells are also positive for CD56 (CD56, ×200).
Squamous cell carcinoma is a rare tumor of the gallbladder,
with a reported incidence of 0.5–12.7% of all malignant tumors of
the gallbladder.16,17 Most form a large mass with invasive growth,
which involves the neighboring organs, such as the duodenum or
transverse colon, but lymph node metastases and peritoneal dis-
semination occur less frequently. The prognosis is extremely poor.
Death occurs within 6 months after the diagnosis in almost all
patients.
Adeno-endocrine cell carcinoma of the gallbladder generally has
a poor prognosis. The present case is only the second case that
achieved long-term survival; the longest survival was 12 years.18
The usual treatment consists of complete removal of the diseased
gallbladder, with the extent of surgery ranging from laparoscopic
cholecystectomy for small lesions to radical cholecystectomy and
regional lymphadenectomy for advanced lesions.8,19 There is no
general agreement on when, or even whether patients with adeno-
endocrine cell carcinoma should receive chemotherapy. Various
drugs, such as doxorubicin, 5-ﬂuorouracil, cisplatin, and strepto-
zocin, have been used either alone or in combination, with poor
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Table 1
Previous case reports of composite tumor (adeno-endocrine cell carcinoma and squamous cell carcinoma) of the gallbladder.
No Author Year Age (years) Sex Size (mm)  Depth Metastasis Therapy Outcomes
1 Iida et al. 1992 62 F 6.5 hinv (+) Liver Cholecystectomy
Resection of the tumor
5  Months
Deceased
2  Maitra et al. 2001 82 F 10 ss Liver ND 8 Months
Deceased
3  Wakabayashi 2003 71 F 100 se None Extended right lobectomy
Partial  resection of colon
36  Months
Alive
4  Mori 2005 70 F 36 × 15 ss LN Cholecystectomy
Resection of liver bed
32  Months
Deceased
5 Present  case 2013 81 F 40 ss LN Cholecystectomy 48  Months
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1N, lymph node; ND, not described; hinv(+), liver invasion, positive; ss, subserosal;
verall response rates. Biotherapy using somatostatin analogs such
s octreotide or lanreotide has been assessed in the treatment of
etastatic disease; it has demonstrated tumorostatic effects with
ymptomatic improvement.10,20
. Conclusion
Adeno-endocrine cell carcinoma of the gallbladder is an uncom-
on neoplasm of the gallbladder, and the diagnosis is often made
ostoperatively on histopathological examination. The present
ase suggests that adeno-endocrine cell carcinoma with various
omponents may  be derived from a common precursor cell. This
bservation would require further investigation.
onﬂict of interest statement
We  have no ﬁnancial and personal relationships with other peo-
le or organizations that could inﬂuence our work.
unding
None.
thical approval
Written informed consent was obtained from the patient for
ublication of this case report and accompanying images. A copy
f the written consent is available for review by the Editor-in-Chief
f this journal on request.
uthor  contributions
T.A.  and K.K. evaluated the patient and wrote the manuscript.
.K., T.G, K.S and N.H. performed the surgery. T.N was  the leader of
he treatment.
eferences1. Tahara E. Endocrine tumors of the gastrointestinal tract: classiﬁcation, function
and  biological behavior. Digestive Disease Pathology 1988;1:121–47.
2. Pilichiwska M,  Kimura N, Ouchi A, et al. Primary hepatic carcinoid and neuroen-
docrine carcinoma: clinicopathological and immunohistochemical study of ﬁve
cases.  Pathology International 1999;49:318–24.
2Resection of liver bed Alive
mor penetrated the serosa without invasion of adjacent structures.
3. Arrigoni MG,  Woolner LB, Beraatz PE. Atypical carcinoid of the lung. Journal of
Thoracic  and Cardiovascular Surgery 1972;49:413–21.
4.  Joel W.  Karzinoid tumor der gallenblase. Zentralblatt fur Allgemeine Pathologie
und Pathologische Anatomie 1929;46:14.
5.  Carriage MT, Henson DE. Liver, gallbladder, extrahepatic bile duct and pancreas.
Cancer 1995;75(Suppl 1):171–90.
6. Yamamoto M,  Nakajo S, Miyoshi N, Nakai S, Tahara E. Endocrine cell car-
cinoma (carcinoid) of the gallbladder. American Journal of Surgical Pathology
1989;13:292–302.
7.  Wada A, Ishiguro S, Tateishi R, Ishikawa O, Matsui Y. Carcinoid tumor
of the gallbladder associated with adenocarcinoma. Cancer 1983;51:
1911–7.
8.  Angelini C, Mussi C, Crippa S, Sartori P, Isimbaldi G, Bonardi C, et al. Gallbladder
carcinoid: a case report. Chirurgia Italiana 2003;55:571–3.
9.  Eriguchi N, Aoyagi S, Noritomi T, Imamura M,  Sato S, Fujiki K, Furukawa S, Shi-
rozu  K, Hayashi I. Adeno-endocrine cell carcinoma of the gallbladder. Journal of
Hepato-Biliary-Pancreatic Surgery 2000;7:97–101.
0.  Mallika T, Vinay K, Raghvendra RM,  Hari SS. Gallbladder carcinoid masquerad-
ing as gallbladder carcinoma. Hepatobiliary and Pancreatic Diseases International
2009;8:326–8.
1. Muto Y, Okamoto K, Uchimura M.  Composite tumor (ordinary adenocarci-
noma, typical carcinoid, and goblet cell adenocarcinoid) of the gallbladder:
a variety of composite tumor. American Journal of Gastroenterology 1984;79:
645–9.
2. Iida Y, Tsutsumi Y. Small cell (endocrine cell) carcinoma of the gallbladder
with squamous and adenocarcinomatous components. Acta Pathologica Japonica
1992;42:119–25.
3.  Maitra A, Tascilar M,  Hruban RH, Offerhaus GJ, Saavedra JA. Small cell carci-
noma of the gallbladder. American Journal of Surgical Pathology 2001;25:596–
601.
4.  Wakabayashi H, Ushiyama T, Sao K, Maeta H. Successful resection of a large
rare  composite tumor (endocrine cell carcinoma and squamous cell carcinoma)
of  the gallbladder after preoperative arterial and portal embolization. Digestive
Surgery 2003;20:457–60.
5. Mori M,  Sato T, Yamamoto K, Seki H, Ishikawa H, Tsutsumi Y. A case of ade-
noendocrine cell carcinoma of the gallbladder with squamous differentiation
in metastatic lymph node: a case report (in Japanese). The Japanese Journal of
Gastroenterological Surgery 2005;38:63–8.
6.  Karasawa T, Itoh K, Komukai M,  Ozawa U, Sakurai I, Shikata T. Squamous cell
carcinoma of the gallbladder, report of two cases and review of literatures. Acta
Pathologica Japonica 1981;31:299–308.
7. Miyazaki K, Tsutsumi N, Kitahara K, Mori M,  Sasatomi E, Tokunaga O, Hisatsugu T.
Hepatopancreatoduodenectomy for squamous and adeno-squamous carcinoma
of  the gallbladder. Hepato-Gastroenterology 1995;42:47–50.
8. Mizukami Y, Nagashima T, Ikuta K, Chikamatsu E, Kurachi K,  Kanemoto H,
Yagi  T, Ohhira S, Nimura Y. Advanced endocrine cell carcinoma of the gall-
bladder: a patient with 12-year survival. Hepato-Gastroenterology 1998;45:
1462–7.
9.  Oku T, Ono K, Nagamachi Y, Misu K, Senmaru N, Fujitaz M,  et al. Pedunculated
carcinoid tumor of the gallbladder—analysis of the relationship between loca-
tion  and morphology in carcinoid tumor of the gallbladder. Nippon Shokakibyo
Gakkai Zasshi 2008;105:397–403.
0. Doherty GM.  Carcinoid tumors and the carcinoid syndrome. In: Devita VTJ, Hell-
man  S, Rosenberg SA, editors. Cancer principles and practice of oncology. 8th ed
Philadelphia: Lippincott Williams & Wilkins; 2008. p. 1721–35.
